Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2020 Filed Feb 2, 2021 22:12 UTC |
Shah Aarti S.SVP & CIDO
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000014 · wf-form5_161230396101811.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,087 Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,709 | $161.98 | $2,706,590.66 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,430,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.63 to $162.39, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 20,831 | $160.90 | $3,351,666.24 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,447,013 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.63 to $161.60, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 125,314 | $160.14 | $20,067,621.05 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,467,844 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.63 to $160.625, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 67,146 | $159.36 | $10,700,708.86 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,593,158 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.63 to $159.625, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 15:29 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 12 | $157.79 | $1,893.48 |
DisclosureSEC source: 0000059478-20-000096 · wf-form4_158756933894103.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,188 Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 15:23 UTC |
Shah Aarti S.SVP & CIO
|
SaleCommon Stock | 2,000 | $150.00 | $300,000.00 |
DisclosureSEC source: 0000059478-20-000094 · wf-form4_158705057891294.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,087 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 89,949 | $145.85 | $13,118,791.80 |
DisclosureSEC source: 0001209191-20-024193 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,660,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.51 to $146.30, inclusive. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:43 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 140,051 | $145.14 | $20,326,750.05 |
DisclosureSEC source: 0001209191-20-024193 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,750,253 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.51 to $145.50, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,900 | $144.69 | $274,901.50 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,890,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.50 to $144.76, inclusive. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 68,927 | $143.91 | $9,919,539.60 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,892,204 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.50 to $144.49, inclusive. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 101,488 | $142.70 | $14,481,840.31 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,961,131 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 15:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,962 | $142.73 | $2,278,321.70 |
DisclosureSEC source: 0001209191-20-023707 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,062,619 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.15, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 18:42 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,279 | $143.68 | $902,173.00 |
DisclosureSEC source: 0001209191-20-023570 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,078,581 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.51 to $143.96, inclusive. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 18:42 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 20,444 | $143.04 | $2,924,319.98 |
DisclosureSEC source: 0001209191-20-023570 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,084,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.4875, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,132 | $142.26 | $872,350.58 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,105,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.69, inclusive. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 43,894 | $141.42 | $6,207,489.48 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,111,436 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.99, inclusive. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 116,012 | $140.46 | $16,294,813.50 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,155,330 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 17:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 38,962 | $140.07 | $5,457,473.58 |
DisclosureSEC source: 0001209191-20-022039 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,271,342 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.44, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 15:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 884 | $137.23 | $121,311.32 |
DisclosureSEC source: 0000059478-20-000086 · wf-form4_158566982249782.xml · nonDerivative · entry 4 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,415 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $136.88 to $137.50. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 15:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 615 | $136.34 | $83,849.10 |
DisclosureSEC source: 0000059478-20-000086 · wf-form4_158566982249782.xml · nonDerivative · entry 3 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,299 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $135.90 to $136.59. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 15:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 1,658 | $135.31 | $224,343.98 |
DisclosureSEC source: 0000059478-20-000086 · wf-form4_158566982249782.xml · nonDerivative · entry 2 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,914 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $134.85 to $135.66. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 15:50 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 11,500 | $133.82 | $1,538,930.00 |
DisclosureSEC source: 0000059478-20-000086 · wf-form4_158566982249782.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,572 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $133.76 to $134.59. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200 | $141.70 | $28,340.00 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,310,304 Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,026 | $140.90 | $2,680,759.59 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,310,504 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.53 to $141.15, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 55,965 | $139.97 | $7,833,460.23 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,329,530 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.52 to $140.51, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 55,973 | $138.98 | $7,778,954.02 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,385,495 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.52 to $139.51, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 78,836 | $138.16 | $10,892,044.83 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,441,468 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.52 to $138.5125, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 14:44 UTC |
Norton JohnaSenior VP, Global Quality
|
SaleCommon Stock | 4,727 | $131.00 | $619,237.00 |
DisclosureSEC source: 0000059478-20-000074 · wf-form4_158454263137522.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,674 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 14:47 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 15 | $129.38 | $1,940.70 |
DisclosureSEC source: 0000059478-20-000076 · wf-form4_158454282875543.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,176 Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 15:46 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
SaleCommon Stock | 25,000 | $140.15 | $3,503,750.00 |
DisclosureSEC source: 0000059478-20-000072 · wf-form4_158350957932757.xml · nonDerivative · entry 1 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 8,469 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.51. The price reported reflects the weighted average purchase price. The spouse of the reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 20:27 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 3,700 | $128.00 | $473,600.00 |
DisclosureSEC source: 0000059478-20-000070 · wf-form4_158326721653347.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,740 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2019. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 20:08 UTC |
Hakim AnatSenior VP & General Counsel
|
GrantRestricted Stock Unit · Derivative | 15,857 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000064 · wf-form4_158326608611601.xml · derivative · entry 1 Hakim Anat · CIK 0001685556 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,857 Underlying: Common Stock · 15,857 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in two installments, 7,928 on March 1, 2021 and 7,929 on March 1, 2022. F2 · derivative.expiration_date: The Restricted Stock Units vest in two installments, 7,928 on March 1, 2021 and 7,929 on March 1, 2022. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 16:26 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 14 | $141.01 | $1,974.14 |
DisclosureSEC source: 0000059478-20-000059 · wf-form4_158221599622492.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,095 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC |
Norton JohnaSenior VP, Global Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · derivative · entry 6 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 0 Underlying: Common Stock · 97 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC |
Norton JohnaSenior VP, Global Quality
|
Tax withholdingCommon Stock | 34 | $141.12 | $4,798.08 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · nonDerivative · entry 2 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 128 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 19:57 UTC |
Norton JohnaSenior VP, Global Quality
|
Exercise / conversionCommon Stock | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000054 · wf-form4_158205580329645.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by partner Disclosed balance after: 162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:34 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GrantRestricted Stock Unit · Derivative | 5,445 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000026 · wf-form4_158163325512066.xml · derivative · entry 3 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,445 Underlying: Common Stock · 5,445 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:34 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GrantCommon Stock | 5,588 | $144.25 | $806,069.00 |
DisclosureSEC source: 0000059478-20-000026 · wf-form4_158163325512066.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,580 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:36 UTC |
Fry Stephen FSVP, HR & Diversity
|
GrantRestricted Stock Unit · Derivative | 15,078 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000028 · wf-form4_158163336663190.xml · derivative · entry 3 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,078 Underlying: Common Stock · 15,078 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:36 UTC |
Fry Stephen FSVP, HR & Diversity
|
GrantCommon Stock | 14,657 | $144.25 | $2,114,272.25 |
DisclosureSEC source: 0000059478-20-000028 · wf-form4_158163336663190.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,072 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:39 UTC |
Jonsson PatrikSVP and Pres., Lilly Bio-Meds
|
GrantCommon Stock | 5,702 | $144.25 | $822,513.50 |
DisclosureSEC source: 0000059478-20-000030 · wf-form4_158163354325735.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,079 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:42 UTC |
Mason Michael BSr. VP & Pres., Lilly Diabetes
|
GrantCommon Stock | 5,785 | $144.25 | $834,486.25 |
DisclosureSEC source: 0000059478-20-000032 · wf-form4_158163371681102.xml · nonDerivative · entry 1 Mason Michael B · CIK 0001799419 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:46 UTC |
Norton JohnaSenior VP, Global Quality
|
GrantRestricted Stock Unit · Derivative | 3,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000034 · wf-form4_158163396149191.xml · derivative · entry 5 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,435 Underlying: Common Stock · 3,435 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:46 UTC |
Norton JohnaSenior VP, Global Quality
|
GrantCommon Stock | 1,778 | $144.25 | $256,476.50 |
DisclosureSEC source: 0000059478-20-000034 · wf-form4_158163396149191.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,401 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:54 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
GrantRestricted Stock Unit · Derivative | 12,146 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000036 · wf-form4_158163446843350.xml · derivative · entry 4 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,146 Underlying: Common Stock · 12,146 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:54 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
GrantCommon Stock | 4,349 | $144.25 | $627,343.25 |
DisclosureSEC source: 0000059478-20-000036 · wf-form4_158163446843350.xml · nonDerivative · entry 1 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,773 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:58 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
GrantRestricted Stock Unit · Derivative | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000038 · wf-form4_158163466596563.xml · derivative · entry 1 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,282 Underlying: Common Stock · 6,282 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:02 UTC |
Ricks David ADirector · President & CEO
|
GrantRestricted Stock Unit · Derivative | 75,387 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000040 · wf-form4_158163491823582.xml · derivative · entry 3 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,387 Underlying: Common Stock · 75,387 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:02 UTC |
Ricks David ADirector · President & CEO
|
GrantCommon Stock | 77,586 | $144.25 | $11,191,780.50 |
DisclosureSEC source: 0000059478-20-000040 · wf-form4_158163491823582.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,252 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.